ICAM1 and gastric cancer: Indeed, Wang et al. designed a novel antibody–drug conjugate (ADC) targeting chromosomally unstable GC (CINGC) using ICAM1 as a molecular target, offering a potential therapeutic approach for this aggressive subtype of GC [77].